Cabergoline, a long-acting dopamine agonist, attenuates L-dopa-induced dyskinesia without L-dopa sparing in a rat model of Parkinson’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cabergoline, a long-acting dopamine agonist, attenuates L-dopa-induced dyskinesia without L-dopa sparing in a rat model of Parkinson’s disease

Published:2022-05 Issue: Volume:178 Page:93-97
ISSN:0168-0102
Container-title:Neuroscience Research
language:en
Short-container-title:Neuroscience Research

Author:

Nishijima Haruo,Mori Fumiaki,Kimura Tamaki,Miki Yasuo,Kinoshita Iku,Nakamura Takashi,Kon Tomoya,Suzuki Chieko,Wakabayashi Koichi,Tomiyama Masahiko

Funder

Hirosaki University

Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science and Technology

Dainippon Sumitomo Pharma

Publisher

Elsevier BV

Subject

General Medicine,General Neuroscience

Reference34 articles.

1. Levodopa-carbidopa intestinal gel in advanced Parkinson’s: final results of the GLORIA registry;Antonini;Park. Relat. Disord.,2017

2. Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys;Belanger;Mov. Disord.,2003

3. Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms;Blanchet;Park. Relat. Disord.,2004

4. Synaptic plasticity may underlie l-DOPA induced dyskinesia;Borgkvist;Curr. Opin. Neurobiol.,2018

5. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study;Bracco;CNS Drugs,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colorimetric Recognition of 3,4-Dihydroxy-D,L-phenylalanine with Tetrapeptide-modified Copper Nanoparticles as Chiral Nanozymes;Chemical Research in Chinese Universities;2023-11-07

2. Endogenous opiates and behavior: 2022;Peptides;2023-11

3. Clinical Application and Synthesis Methods of Deuterated Drugs;Current Medicinal Chemistry;2022-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3